Exposure to phthalate-containing prescription drugs and the risk of colorectal adenocarcinoma: A Danish nationwide case-control study.
Zandra Nymand EnnisJesper HallasThomas Patrick AhernNina Sahlertz KristiansenPer DamkierPublished in: Pharmacoepidemiology and drug safety (2019)
We found an apparent overall protective effect of cumulative phthalate exposure from drug excipients for colorectal adenocarcinoma. Omitting NSAID users reversed the signal and suggested a slightly increased risk associated with high cumulative ortho-phthalate exposure.